04/29/2025
11:15 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form EFFECT | |
04/25/2025
1:38 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/24/2025
2:09 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
04/21/2025
5:08 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2025
4:00 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/02/2025
3:42 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
2:31 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form NT 10-K | |
03/25/2025
1:19 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/24/2025
10:03 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
5:01 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form PRE 14C | |
03/14/2025
5:00 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for CYCC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/04/2025
9:32 AM | Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Doris Wong Sing Ee (Filed by)
| Form SCHEDULE 13D | |
02/28/2025
3:46 PM | Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Lazar David E. (Filed by)
| Form SCHEDULE 13D | |
02/28/2025
3:47 PM | Ben-Tzvi Avraham (Reporting)
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:48 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Lazar David E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:48 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
NATAN DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
10:31 AM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Kiu Cu Seng (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/28/2025
10:31 AM | Chong Kwang Fock (Reporting)
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/28/2025
10:32 AM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Doris Wong Sing Ee (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/24/2025
7:31 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:40 PM | ARMISTICE CAPITAL, LLC (Filed by)
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
4:45 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Lazar David E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:46 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
3:40 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
5:02 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
01/10/2025
3:46 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form PRER14A | |
01/10/2025
5:04 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
4:25 PM | Ben-Tzvi Avraham (Reporting)
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2025
5:30 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form PRE 14A | |
01/07/2025
6:04 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Lazar David E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/07/2025
6:06 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
NATAN DAVID (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/07/2025
6:07 PM | Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
NATAN DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:17 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
3:15 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
5:38 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/15/2024
5:05 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:21 PM | Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Lind Global Fund II LP (Filed by)
| Form SC 13G/A | |
11/12/2024
4:10 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
4:00 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
8:00 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form RW | |
10/24/2024
3:00 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
10/09/2024
5:00 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
08/30/2024
8:08 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2024
3:15 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2024
3:00 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/24/2024
8:34 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
8:56 AM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
05/14/2024
4:12 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
3:05 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
11:15 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form EFFECT | |
05/07/2024
8:53 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
05/07/2024
8:56 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form ARS | |
05/07/2024
8:52 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
05/06/2024
4:26 PM | Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
Buy CYCC Stock Free CYCC Stock Alerts